Use of flibanserin in the treatment of premenstrual and other female sexual disorders

Details for Australian Patent Application No. 2005235423 (hide)

Owner Boehringer Ingelheim Pharmaceuticals, Inc.

Inventors Pyke, Robert

Agent Davies Collison Cave

Pub. Number AU-A-2005235423

PCT Pub. Number WO2005/102343

Priority 60/564,660 22.04.04 US

Filing date 18 April 2005

Wipo publication date 3 November 2005

International Classifications

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

Event Publications

7 December 2006 PCT application entered the National Phase

  PCT publication WO2005/102343 Priority application(s): WO2005/102343

10 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005235428-Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders

2005235422-New pharmaceutical compositions for the treatment of sexual disorders II